{
  "id": 270232,
  "title": "China biotech will slow as it nears R&D frontier, Pfizer’s Baum predicts",
  "url": "https://urgent.news/2026/08/07/china-biotech-will-slow-as-it-nears-r-d-frontier-pfizers-baum-predicts",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-07T15:00:01.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/china-biotech-will-slow-as-it-nears-rd-frontier-pfizers-baum-predicts/"
  },
  "original_language": "en",
  "account": null,
  "summary": "China’s rapid advance in biotech will slow as companies there begin to experiment on the cutting edge of R&D, according to Pfizer’s Andrew Baum, who expects the risks of biology and drug development will create ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Endpoints News",
        "title": "The China Debate: Biotech deserves a deeper discussion",
        "url": "https://urgent.news/2026/08/04/the-china-debate-biotech-deserves-a-deeper-discussion",
        "published": "2026-08-04T18:20:59.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}